According to Galectin Therapeutics's latest financial reports and stock price the company's current number of shares outstanding is 59,704,000. At the end of 2023 the company had 59,704,000 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Year | Shares Outstanding | Change |
---|---|---|
2023 | 59.7 M | 0.52% |
2022 | 59.39 M | 0.18% |
2021 | 59.29 M | 3.93% |
2020 | 57.04 M | 0.73% |
2019 | 56.63 M | 38.39% |
2018 | 40.92 M | 16.37% |
2017 | 35.16 M | 20.09% |
2016 | 29.28 M | 23.07% |
2015 | 23.79 M | 7.9% |
2014 | 22.05 M | 29.8% |
2013 | 16.98 M | 7.37% |
2012 | 15.82 M |
Company | Shares Outstanding | differencediff. | Country |
---|---|---|---|
Mirati Therapeutics MRTX | 64,993,079 | 8.86% | ๐บ๐ธ USA |
MannKind Corp MNKD | 268,732,000 | 350.11% | ๐บ๐ธ USA |